References
- Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020;76(21): 2492–2516 .
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35–e71.
- Jones DR, Chew DP, Horsfall MJ, et al. Multidisciplinary transcatheter aortic valve replacement heart team programme improves mortality in aortic stenosis. Open Heart. 2019;6(2):e000983. doi:https://doi.org/10.1136/openhrt-2018-000983.
- Thourani V, Brennan J, Edelman J, et al. Treatment patterns, disparities and management strategies impact clinical outcomes in patients with symptomatic severe aortic regurgitation. Struct Heart. 2021:1–11. (in-press). doi:https://doi.org/10.1080/24748706.2021.1988779.
- Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol. 2017;70(22):2752–2763. doi:https://doi.org/10.1016/j.jacc.2017.10.006.
- Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv. 2017;10(10):1048–1056. doi:https://doi.org/10.1016/j.jcin.2017.03.004.
- Franzone A, Piccolo R, Siontis GCM, et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv. 2016;9(22):2308–2317. doi:https://doi.org/10.1016/j.jcin.2016.08.049.
- Silaschi M, Conradi L, Wendler O, et al. The Jupiter registry: one-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation. Catheter Cardiovasc Interv. 2018;91(7):1345–1351. doi:https://doi.org/10.1002/ccd.27370.
- THE ALIGN-AR PIVOTAL TRIAL: JenaValve pericardial TAVR aortic regurgitation study (ALIGN-AR). https://www.clinicaltrials.gov/ct2/show/NCT04415047. Accessed October 10, 2021.
- Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011. doi:https://doi.org/10.1016/S0140-6736(06)69208-8.
- Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102(1):75–85. doi:https://doi.org/10.1136/heartjnl-2014-307020.
- Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–1012. doi:https://doi.org/10.1016/j.jacc.2013.05.015.